Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00731
Species: Homo sapiens
Position : chr1:47669000-47669500
Year: 2014
Title: Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: T-cell acute lymphoblastic leukemia
PMID:  25394790
MONDO: MONDO:0004963
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: Jurkat and TAL1-mutant primary T-ALL
CVCL ID: CVCL_0367
Cell Type: T lymphoblast
Cell Ontology ID: CL:0000084
Experiment Type: Mutation-created neo-enhancer and TF recruitment
High Throughput Method: H3K27ac ChIP-seq; TF ChIP-seq
Low Throughput Method: Reporter assay; mutation analysis; allele-specific enhancer assay
About Target Gene
Target gene : TAL1
About TF
TF name : MYB
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
MYB AP-1 transcription factor network pid 71
MYB C-MYB transcription factor network pid 87
MYB Factors involved in megakaryocyte development and platelet production reactome 111
MYB IL2 signaling events mediated by PI3K pid 38
MYB IL4-mediated signaling events pid 66
MYB Notch-mediated HES/HEY network pid 48
MYB Prolactin netpath 105
MYB Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00732 chr1:47669000-47669500 blood T lymphoblast T-cell acute lymphoblastic leukemia
E_00733 chr1:47669000-47669500 blood T lymphoblast T-cell acute lymphoblastic leukemia
E_00734 chr1:47669000-47669500 blood T lymphoblast T-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer